Cancer Research Frontiers is a newly launched, open access, peer-reviewed, scholarly journal (ISSN 2328-5249), dedicated to publishing articles on broad aspects of cancer research. The journal will focus on molecular, genetic, cellular and clinical studies of cancer.
The journal aims to be a valuable reference for the publication of high-quality, original research and review articles that make novel and important contributions to understanding the biological behavior of cancer.
The journal will publish inauguration issues every four months from 2015-2016. In 2017, it moves to a yearly schedule and will publish articles as soon as they are ready.
Few areas can benefit as much from Open Access as can cancer research. Public, scientific, and governmental interest in cancer is increasing. At the same time, misinformation, unsubstantiated opinions, and unsourced data also are increasing. Thus, public access to reliable, peer-reviewed cancer research is of utmost importance. Cancer Research Frontiers is a response to a need within the scientific community for the unbiased reporting of cancer research findings in a high-profile, fully accessible forum, with free access to the entire world.
Cancer Research Frontiers provides:
- Open-access—freely accessible online
- Authors right to retain copyright
- Fair and rigorous peer review
- Fast publication times-Initial decisions within four weeks
- Low publication fees-US$500
Impact factor
As a newly launched journal, we don’t have impact factor right now.
Our goal
When we started this journal, our editorial team set a goal: middle-high journal ranking within the categories of oncology, with an initial impact factor between 3 and 5, and even higher later. We believe our goal are attainable because of our peer-review methods (quick and fair), a robust stream of submissions from top researchers, and a cadre of prestigious editors and reviewers.
Ownership and management
It has been financially supported and owned by World Biomedical Frontiers, LLC (http://biomedfrontiers.com/)
